{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:01:45Z","timestamp":1793109705014,"version":"4.5.0"},"reference-count":526,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1124\/pharmrev.120.000007","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T19:15:23Z","timestamp":1707419723000},"page":"323-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview"],"prefix":"10.1016","volume":"76","author":[{"given":"Analia","family":"Bortolozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Fico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars V.","family":"Kessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pharmrev.120.000007_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pnpbp.2012.11.015","article-title":"Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats","volume":"43","author":"Abrial","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0006-3223(01)01195-7","article-title":"Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex","volume":"50","author":"Adams","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bdi.13041","article-title":"Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder","volume":"23","author":"Ahmad","year":"2021","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41386-019-0556-8","article-title":"Exploring lithium\u2019s transcriptional mechanisms of action in bipolar disorder: a multi-step study","volume":"45","author":"Akkouh","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/mp.2015.4","article-title":"Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics","volume":"20","author":"Alda","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fnins.2018.00386","article-title":"Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression","volume":"12","author":"Allen","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib901","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1038\/s41380-020-0689-5","article-title":"Association of polygenic score for major depression with response to lithium in patients with bipolar disorder","volume":"26","author":"Amare","year":"2021","journal-title":"Molecular psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00213-020-05465-4","article-title":"Hippocampal and prefrontal cortical NMDA receptors mediate the interactive effects of olanzapine and lithium in memory retention in rats: the involvement of CAMKII-CREB signaling pathways","volume":"237","author":"Amiri","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.120.000007_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jad.2010.08.015","article-title":"Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania","volume":"129","author":"Amrollahi","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41398-020-0784-z","article-title":"Integrative analysis of lithium treatment associated effects on brain structure and peripheral gene expression reveals novel molecular insights into mechanism of action","volume":"10","author":"Anand","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/bdi.12998","article-title":"Commentary on: \u201cMake lithium great again!\u201d","volume":"23","author":"Anmella","year":"2021","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00018-006-6010-1","article-title":"Neurotrophin signaling: many exciting surprises!","volume":"63","author":"Ar\u00e9valo","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pharmrev.120.000007_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euroneuro.2018.01.005","article-title":"Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies","volume":"28","author":"Artigas","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.113996","article-title":"Phosphorylation of PI3K\/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice","volume":"351","author":"Ates","year":"2022","journal-title":"Exp Neurol"},{"key":"10.1124\/pharmrev.120.000007_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.120.000007_bib15","doi-asserted-by":"crossref","first-page":"aac4354","DOI":"10.1126\/science.aac4354","article-title":"In vivo aspects of protein folding and quality control","volume":"353","author":"Balchin","year":"2016","journal-title":"Science"},{"key":"10.1124\/pharmrev.120.000007_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-2011-101989","article-title":"Autophagy in aging and Alzheimer\u2019s disease: pathologic or protective?","volume":"25","author":"Barnett","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/pharmrev.120.000007_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fncel.2019.00196","article-title":"Dual Role of Autophagy in Diseases of the Central Nervous System","volume":"13","author":"Bar-Yosef","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"Suppl 3","key":"10.1124\/pharmrev.120.000007_bib18","first-page":"S250","article-title":"Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders","volume":"36","author":"Bauer","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000470803","article-title":"The Link between Refractoriness and Neuroprogression in Treatment-Resistant Bipolar Disorder","volume":"31","author":"Bauer","year":"2017","journal-title":"Mod Trends Pharmacopsychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1176\/appi.ajp.157.9.1429","article-title":"Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression","volume":"157","author":"Bauer","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2022.03.007","article-title":"Lithium: What can we do to overcome the discrepancies between evidence, guideline recommendations and clinical practice?","volume":"60","author":"Bauer","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib22","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000007_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2007.11.041","article-title":"A beta-arrestin 2 signaling complex mediates lithium action on behavior","volume":"132","author":"Beaulieu","year":"2008","journal-title":"Cell"},{"key":"10.1124\/pharmrev.120.000007_bib24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/tpj.2013.16","article-title":"Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS)","volume":"14","author":"Beech","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/pharmrev.120.000007_bib25","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1111\/ene.14936","article-title":"European Academy of Neurology and European Federation of Neurorehabilitation Societies guideline on pharmacological support in early motor rehabilitation after acute ischaemic stroke","volume":"28","author":"Beghi","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1124\/pharmrev.120.000007_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1871527315666160321104613","article-title":"Endoplasmic Reticulum Stress and Bipolar Disorder - Almost Forgotten Therapeutic Drug Targets in the Unfolded Protein Response Pathway Revisited","volume":"15","author":"Bengesser","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1124\/pharmrev.120.000007_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2194-7511-1-11","article-title":"Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients","volume":"1","author":"Bergh\u00f6fer","year":"2013","journal-title":"Int J Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00004850-199911000-00003","article-title":"Olanzapine compared to lithium in mania: a double-blind randomized controlled trial","volume":"14","author":"Berk","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S1461145708009498","article-title":"Neuroprogression: pathways to progressive brain changes in bipolar disorder","volume":"12","author":"Berk","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1399-5618.2011.00889.x","article-title":"Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention","volume":"13","author":"Berk","year":"2011","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib31","article-title":"Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume","volume":"7","author":"Berk","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-6-9","article-title":"Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain","volume":"6","author":"Beurel","year":"2009","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.120.000007_bib34","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/mp.2011.47","article-title":"Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice","volume":"16","author":"Beurel","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.129","article-title":"Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits","volume":"4","author":"Beurel","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pharmrev.120.000007_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainres.2007.01.147","article-title":"Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment","volume":"1147","author":"Bezchlibnyk","year":"2007","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000007_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.brainres.2007.09.054","article-title":"Lithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbils","volume":"1184","author":"Bian","year":"2007","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000007_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/a-1348-1523","article-title":"Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram","volume":"54","author":"Bohlken","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib41","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","article-title":"Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer\u2019s disease","volume":"28","author":"Boland","year":"2008","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2014.03.005","article-title":"Clinical and biological changes under treatment with lithium carbonate and valproic acid in sporadic amyotrophic lateral sclerosis","volume":"340","author":"Boll","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107873","article-title":"Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson\u2019s disease","volume":"227","author":"Bortolozzi","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pharmrev.120.000007_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pnpbp.2016.02.004","article-title":"A differential impact of lithium on endothelium-dependent but not on endothelium-independent vessel relaxation","volume":"67","author":"Bosche","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.22056","article-title":"Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden","volume":"6","author":"Bosi","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1124\/pharmrev.120.000007_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jad.2004.01.007","article-title":"Cytokine production in bipolar affective disorder patients under lithium treatment","volume":"82","author":"Boufidou","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/tpj.2016.50","article-title":"Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines","volume":"16","author":"Breen","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/pharmrev.120.000007_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0404.2011.01595.x","article-title":"Post-stroke depression and functional independence: a conundrum","volume":"126","author":"Brown","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1124\/pharmrev.120.000007_bib49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/JCP.0b013e31827b9495","article-title":"Acute antidepressive efficacy of lithium monotherapy, not citalopram, depends on recurrent course of depression","volume":"33","author":"Bschor","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib50","article-title":"Letter of response to Nabi Z, Stansfeld J, Pl\u00f6derl M, Wood L, Moncrieff J. Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials","volume":"31","author":"Bschor","year":"2022","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1124\/pharmrev.120.000007_bib51","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41386-020-0683-2","article-title":"The association between lithium use and neurocognitive performance in patients with bipolar disorder","volume":"45","author":"Burdick","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02265","article-title":"Proteomic measures of gamma oscillations","volume":"5","author":"Byrum","year":"2019","journal-title":"Heliyon"},{"key":"10.1124\/pharmrev.120.000007_bib53","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00210-013-0893-9","article-title":"Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system","volume":"386","author":"Caberlotto","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","article-title":"Lithium salts in the treatment of psychotic excitement","volume":"2","author":"Cade","year":"1949","journal-title":"Med J Aust"},{"key":"10.1124\/pharmrev.120.000007_bib55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.eurpsy.2004.12.003","article-title":"New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder","volume":"20","author":"Calabrese","year":"2005","journal-title":"Eur Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313070","article-title":"Augmentative pharmacological strategies in treatment-resistant major depression: A comprehensive review","volume":"22","author":"Caldiroli","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.114.152850","article-title":"Insulin resistance and outcome in bipolar disorder","volume":"206","author":"Calkin","year":"2015","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib58","first-page":"21m14022","article-title":"Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial","volume":"83","author":"Calkin","year":"2022","journal-title":"J Clinl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib59","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1124\/pharmrev.120.000007_bib60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson\u2019s disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pharmrev.120.000007_bib61","doi-asserted-by":"crossref","first-page":"pyu079","DOI":"10.1093\/ijnp\/pyu079","article-title":"Treatment implications of predominant polarity and the polarity index: a comprehensive review","volume":"18","author":"Carvalho","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar Disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.120.000007_bib63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/bdi.13031","article-title":"The rebirth of lithium as the archetypal mood stabilizer","volume":"23","author":"Carvalho","year":"2021","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib64","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.peptides.2009.07.004","article-title":"Lithium attenuates behavioral and biochemical effects of neuropeptide S in mice","volume":"30","author":"Castro","year":"2009","journal-title":"Peptides"},{"key":"10.1124\/pharmrev.120.000007_bib65","first-page":"1","article-title":"Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach","volume":"28","author":"Cearns","year":"2022","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib66","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1046\/j.1471-4159.1994.63062361.x","article-title":"Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro","volume":"63","author":"Chen","year":"1994","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000007_bib67","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1399-5618.2000.20303.x","article-title":"Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo","volume":"2","author":"Chen","year":"2000","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib68","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0006-3223(00)00878-7","article-title":"Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus","volume":"48","author":"Chen","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s42003-022-03051-2","article-title":"The neuroprotective mechanism of lithium after ischaemic stroke","volume":"5","author":"Chen","year":"2022","journal-title":"Commun Biol"},{"key":"10.1124\/pharmrev.120.000007_bib910","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1212444","article-title":"Variant GADL1 and response to lithium therapy in bipolar I disorder","volume":"370","author":"Chen","year":"2014","journal-title":"The New England journal of medicine"},{"key":"10.1124\/pharmrev.120.000007_bib70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.yco.0000218604.63463.cd","article-title":"The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers","volume":"19","author":"Chen","year":"2006","journal-title":"Curr Opin Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib71","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1046\/j.1471-4159.2000.0751729.x","article-title":"Enhancement of hippocampal neurogenesis by lithium","volume":"75","author":"Chen","year":"2000","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000007_bib72","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1017\/S1461145709000029","article-title":"MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment","volume":"12","author":"Chen","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib73","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1074\/jbc.274.10.6039","article-title":"Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity","volume":"274","author":"Chen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000007_bib74","article-title":"GSK-3\u03b2 downregulates Nrf2 in cultured cortical neurons and in a rat model of cerebral ischemia-reperfusion","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.120.000007_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003941","article-title":"Association between lithium use and the incidence of dementia and its subtypes: A retrospective cohort study","volume":"19","author":"Chen","year":"2022","journal-title":"PLoS Med"},{"key":"10.1124\/pharmrev.120.000007_bib76","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.23743","article-title":"Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood","volume":"3","author":"Cheng","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"10.1124\/pharmrev.120.000007_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbi.2015.12.012","article-title":"Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior","volume":"53","author":"Cheng","year":"2016","journal-title":"Brain Behav Immun"},{"issue":"Suppl 2","key":"10.1124\/pharmrev.120.000007_bib78","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1586\/14737175.4.6.S17","article-title":"Treatment of bipolar mania with atypical antipsychotics","volume":"4","author":"Chengappa","year":"2004","journal-title":"Expert Rev Neurother"},{"key":"10.1124\/pharmrev.120.000007_bib79","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jep.2011.08.008","article-title":"Anti-inflammatory effects of Polygala tenuifolia root through inhibition of NF-\u03baB activation in lipopolysaccharide-induced BV2 microglial cells","volume":"137","author":"Cheong","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib80","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","article-title":"Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington\u2019s disease","volume":"36","author":"Chiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib81","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder","volume":"65","author":"Chiu","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.120.000007_bib82","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.biopsych.2011.11.006","article-title":"1H-[13C]-nuclear magnetic resonance spectroscopy measures of ketamine\u2019s effect on amino acid neurotransmitter metabolism","volume":"71","author":"Chowdhury","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib83","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.neuron.2014.04.003","article-title":"Calcium-dependent PKC isoforms have specialized roles in short-term synaptic plasticity","volume":"82","author":"Chu","year":"2014","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.120.000007_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112719","article-title":"Neuroprotective effect of lithium in cold- induced traumatic brain injury in mice","volume":"392","author":"Ciftci","year":"2020","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.120.000007_bib85","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1871527315666161213110518","article-title":"Mitochondrial Dysfunctions in Bipolar Disorder: Effect of the Disease and Pharmacotherapy","volume":"16","author":"Cikankova","year":"2017","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1124\/pharmrev.120.000007_bib86","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.120.000007_bib87","doi-asserted-by":"crossref","first-page":"f3646","DOI":"10.1136\/bmj.f3646","article-title":"Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis","volume":"346","author":"Cipriani","year":"2013","journal-title":"BMJ"},{"key":"10.1124\/pharmrev.120.000007_bib88","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/jcph.2089","article-title":"Lithium Pharmacokinetics in the Perinatal Patient With Bipolar Disorder","volume":"62","author":"Clark","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib89","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3390\/genes13061038","article-title":"Circulating miRNAs as Potential Biomarkers for Patient Stratification in Bipolar Disorder: A Combined Review and Data Mining Approach","volume":"13","author":"Clausen","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1124\/pharmrev.120.000007_bib985","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S2215-0366(15)00316-8","article-title":"Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study","volume":"2","author":"Clos","year":"2015","journal-title":"The lancet Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib90","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/35096075","article-title":"The renaissance of GSK3","volume":"2","author":"Cohen","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/pharmrev.120.000007_bib91","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.eurpsy.2015.09.009","article-title":"Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial","volume":"30","author":"Conus","year":"2015","journal-title":"Eur Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib92","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000519707","article-title":"Association of Attention-Deficit\/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study","volume":"7","author":"Coombes","year":"2021","journal-title":"Complex Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib93","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2147\/NDT.S135623","article-title":"Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review","volume":"13","author":"Correia-Melo","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1124\/pharmrev.120.000007_bib94","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.encep.2016.02.003","article-title":"The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature","volume":"42","author":"Costemale-Lacoste","year":"2016","journal-title":"Encephale"},{"key":"10.1124\/pharmrev.120.000007_bib95","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41386-019-0365-0","article-title":"Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial","volume":"44","author":"Costi","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib96","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1124\/pharmrev.120.000007_bib97","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fpsyt.2018.00739","article-title":"Mitochondria, Microglia, and the Immune System-How Are They Linked in Affective Disorders?","volume":"9","author":"Culmsee","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib98","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neulet.2005.12.085","article-title":"Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes","volume":"398","author":"Cunha","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000007_bib99","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.ypg.0000056684.89558.d2","article-title":"Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q","volume":"13","author":"Curtis","year":"2003","journal-title":"Psychiatr Genet"},{"key":"10.1124\/pharmrev.120.000007_bib100","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/npp.2012.10","article-title":"Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII","volume":"37","author":"D\u2019Addario","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib102","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40345-017-0108-2","article-title":"Cognitive functioning following stabilisation from first episode mania","volume":"5","author":"Daglas","year":"2017","journal-title":"Int J Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib103","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/ijms22010189","article-title":"Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer\u2019s Disease, Lithium, and Autophagy","volume":"22","author":"Damri","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib104","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.pa.11.040171.001441","article-title":"Lithium","volume":"11","author":"Davis","year":"1971","journal-title":"Annu Rev Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12882-018-1101-4","article-title":"Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification","volume":"19","author":"Davis","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1124\/pharmrev.120.000007_bib106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/pharmrev.120.000007_bib107","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1517\/14656566.2012.719876","article-title":"Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance","volume":"13","author":"de Bartolomeis","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/pharmrev.120.000007_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189485","article-title":"Lithium reduces blood glucose levels, but aggravates albuminuria in BTBR-ob\/ob mice","volume":"12","author":"de Groot","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000007_bib109","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1351\/pac200375060683","article-title":"Atomic weights of the elements: Review 2000 (IUPAC Technical Report)","volume":"75","author":"de Laeter","year":"2003","journal-title":"Pure Appl Chem"},{"key":"10.1124\/pharmrev.120.000007_bib110","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2147\/NDT.S106479","article-title":"A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts","volume":"12","author":"Dell\u2019Osso","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1124\/pharmrev.120.000007_bib111","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neubiorev.2020.06.017","article-title":"Lithium and suicide prevention in mood disorders and in the general population: A systematic review","volume":"116","author":"Del Matto","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pharmrev.120.000007_bib112","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2011.02.054","article-title":"Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study","volume":"494","author":"de Sousa","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000007_bib113","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-014-3655-6","article-title":"Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes","volume":"232","author":"de Sousa","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.120.000007_bib114","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpsychires.2013.11.011","article-title":"Oxidative stress in early stage Bipolar Disorder and the association with response to lithium","volume":"50","author":"de Sousa","year":"2014","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pharmrev.120.000007_bib115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2147\/NDT.S33086","article-title":"Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders","volume":"9","author":"Diniz","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1124\/pharmrev.120.000007_bib116","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/15622975.2010.551408","article-title":"Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?","volume":"12","author":"Diniz","year":"2011","journal-title":"World J Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib117","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1124\/pharmrev.120.000007_bib118","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/0271678X16647738","article-title":"Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3\u03b2 inhibition-independent pathways","volume":"37","author":"Doeppner","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/pharmrev.120.000007_bib119","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.euroneuro.2018.10.003","article-title":"Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study","volume":"28","author":"Dold","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12974-014-0140-4","article-title":"Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K\/Akt\/FoxO1 pathway","volume":"11","author":"Dong","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.120.000007_bib121","first-page":"122","article-title":"Role of calcium channels in bipolar disorder","volume":"6","author":"D\u2019Onofrio","year":"2017","journal-title":"Curr Psychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib122","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1523\/JNEUROSCI.2164-05.2005","article-title":"Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis","volume":"25","author":"Dou","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib123","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.201005144","article-title":"Protein homeostasis and aging in neurodegeneration","volume":"190","author":"Douglas","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1124\/pharmrev.120.000007_bib124","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14728222.2018.1526925","article-title":"Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging","volume":"22","author":"Duda","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"10.1124\/pharmrev.120.000007_bib125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"key":"10.1124\/pharmrev.120.000007_bib126","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.120.000007_bib127","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fnins.2014.00457","article-title":"Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins","volume":"8","author":"Dwivedi","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib128","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1017\/S1461145709990575","article-title":"Aberrant extracellular signal-regulated kinase (ERK)1\/2 signalling in suicide brain: role of ERK kinase 1 (MEK1)","volume":"12","author":"Dwivedi","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib129","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.biopsych.2009.12.004","article-title":"Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder","volume":"67","author":"Eastwood","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib130","first-page":"240","article-title":"Acute and chronic effects of lithium on BDNF and GDNF mRNA and protein levels in rat primary neuronal, astroglial and neuroastroglia cultures","volume":"18","author":"Emamghoreishi","year":"2015","journal-title":"Iran J Basic Med Sci"},{"key":"10.1124\/pharmrev.120.000007_bib131","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1471-4159.2006.04139.x","article-title":"Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert","volume":"99","author":"Engel","year":"2006","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000007_bib132","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jpsychires.2020.12.041","article-title":"Clinical predictors of recurrences in bipolar disorders type 1 and 2: A FACE-BD longitudinal study","volume":"134","author":"Etain","year":"2021","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pharmrev.120.000007_bib133","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10072-014-1943-x","article-title":"Protective effects of lithium chloride treatment on repeated cerebral ischemia-reperfusion injury in mice","volume":"36","author":"Fan","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib134","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1073\/pnas.220413597","article-title":"Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A","volume":"97","author":"Fang","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000007_bib135","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpsychires.2011.03.002","article-title":"Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis","volume":"45","author":"Fernandes","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pharmrev.120.000007_bib136","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12916-015-0529-7","article-title":"Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies","volume":"13","author":"Fernandes","year":"2015","journal-title":"BMC Med"},{"key":"10.1124\/pharmrev.120.000007_bib137","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jad.2021.07.062","article-title":"Duration of untreated illness and bipolar disorder: time for a new definition? Results from a cross-sectional study","volume":"294","author":"Fico","year":"2021","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib138","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2017.05.016","article-title":"Nutrients, neurogenesis and brain ageing: From disease mechanisms to therapeutic opportunities","volume":"141","author":"Fidaleo","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib139","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0896-6273(00)80866-1","article-title":"CREB couples neurotrophin signals to survival messages","volume":"25","author":"Finkbeiner","year":"2000","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.120.000007_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014382","article-title":"Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice","volume":"5","author":"Fiorentini","year":"2010","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000007_bib141","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/11599180-000000000-00000","article-title":"Does lithium prevent Alzheimer\u2019s disease?","volume":"29","author":"Forlenza","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1124\/pharmrev.120.000007_bib142","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/cn5000309","article-title":"Neuroprotective effects of lithium: implications for the treatment of Alzheimer\u2019s disease and related neurodegenerative disorders","volume":"5","author":"Forlenza","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib143","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1192\/bjp.2019.76","article-title":"Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial","volume":"215","author":"Forlenza","year":"2019","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib144","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1073\/pnas.0708022105","article-title":"Lithium delays progression of amyotrophic lateral sclerosis","volume":"105","author":"Fornai","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000007_bib145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1745017901612010142","article-title":"Does the \u201cSilver Bullet\u201d Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients","volume":"12","author":"Fornaro","year":"2016","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"10.1124\/pharmrev.120.000007_bib146","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/NDT.S100846","article-title":"Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review","volume":"12","author":"Fornaro","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1124\/pharmrev.120.000007_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.159","article-title":"Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder","volume":"5","author":"Forstner","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib148","first-page":"180","article-title":"The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib149","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.euroneuro.2021.10.003","article-title":"Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses","volume":"54","author":"Fountoulakis","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/appi.ajp.2019.19030228","article-title":"Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes","volume":"177","author":"Fornaro","year":"2020","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib151","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2012.00014","article-title":"Inhibition of GSK3 by lithium, from single molecules to signaling networks","volume":"5","author":"Freland","year":"2012","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib152","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.lfs.2006.01.002","article-title":"Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania","volume":"79","author":"Frey","year":"2006","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.120.000007_bib153","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jad.2017.09.025","article-title":"The miRNome of bipolar disorder","volume":"233","author":"Fries","year":"2018","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib154","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jpsychires.2015.05.006","article-title":"Memory and brain-derived neurotrophic factor after subchronic or chronic amphetamine treatment in an animal model of mania","volume":"68","author":"Fries","year":"2015","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pharmrev.120.000007_bib155","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s002130100871","article-title":"Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain","volume":"158","author":"Fukumoto","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.120.000007_bib156","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.rpsm.2021.09.002","article-title":"Ketamine triggers rapid antidepressant effects by modulating synaptic plasticity in a new depressive-like mouse model based on astrocyte glutamate transporter GLT-1 knockdown in infralimbic cortex","volume":"15","author":"Fullana","year":"2022","journal-title":"Rev Psiquiatr Salud Ment (Engl Ed)"},{"key":"10.1124\/pharmrev.120.000007_bib157","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/medicina59010120","article-title":"Divergent Directionality of Immune Cell-Specific Protein Expression between Bipolar Lithium Responders and Non-Responders Revealed by Enhanced Flow Cytometry","volume":"59","author":"Gao","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1124\/pharmrev.120.000007_bib158","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2019.04.002","article-title":"Depression in neurodegenerative diseases: Common mechanisms and current treatment options","volume":"102","author":"Galts","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pharmrev.120.000007_bib159","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/FBP.0000000000000505","article-title":"Mitochondrial metabolism: a common link between neuroinflammation and neurodegeneration","volume":"30","author":"Garabadu","year":"2019","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/bdi.12735","article-title":"Bottom-up gamma and bipolar disorder, clinical and neuroepigenetic implications","volume":"21","author":"Garcia-Rill","year":"2019","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib161","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2005.01.008","article-title":"Causes of reversible nephrogenic diabetes insipidus: a systematic review","volume":"45","author":"Garofeanu","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/pharmrev.120.000007_bib162","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jnc.12203","article-title":"AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans","volume":"125","author":"Georgievska","year":"2013","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000007_bib163","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.120.000007_bib164","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.drudis.2016.01.016","article-title":"Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity","volume":"21","author":"Gerhard","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1124\/pharmrev.120.000007_bib165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/cpt1970112168","article-title":"Lithium in mania","volume":"11","author":"Gershon","year":"1970","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pharmrev.120.000007_bib166","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nlm.2015.11.015","article-title":"Role of hippocampal and prefrontal cortical signaling pathways in dextromethorphan effect on morphine-induced memory impairment in rats","volume":"128","author":"Ghasemzadeh","year":"2016","journal-title":"Neurobiol Learn Mem"},{"key":"10.1124\/pharmrev.120.000007_bib167","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25480","article-title":"Chronic lithium treatment elicits its antimanic effects via BDNF-TrkB dependent synaptic downscaling","volume":"6","author":"Gideons","year":"2017","journal-title":"eLife"},{"key":"10.1124\/pharmrev.120.000007_bib168","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/glia.23271","article-title":"Bioenergetic regulation of microglia","volume":"66","author":"Ghosh","year":"2018","journal-title":"Glia"},{"key":"10.1124\/pharmrev.120.000007_bib169","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neubiorev.2021.11.026","article-title":"Does metabolic syndrome or its component factors alter the course of bipolar disorder? A systematic review","volume":"132","author":"Gim\u00e9nez-Palomo","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pharmrev.120.000007_bib170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin","year":"2016","journal-title":"Int J Bipolar disord"},{"issue":"Suppl 2","key":"10.1124\/pharmrev.120.000007_bib171","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1399-5618.2009.00716.x","article-title":"Identifying and treating cognitive impairment in bipolar disorder","volume":"11","author":"Goldberg","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib172","doi-asserted-by":"crossref","first-page":"F1168","DOI":"10.1152\/ajprenal.00145.2016","article-title":"What we need to know about the effect of lithium on the kidney","volume":"311","author":"Gong","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pharmrev.120.000007_bib173","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1399-5618.2006.00368.x","article-title":"Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment","volume":"8","author":"Gonzalez-Pinto","year":"2006","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2021.07.011","article-title":"Lithium therapy and weight change in people with bipolar disorder: A systematic review and meta-analysis","volume":"134","author":"Gomes-da-Costa","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pharmrev.120.000007_bib177","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.npp.1300283","article-title":"In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3","volume":"29","author":"Gould","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib178","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40263-015-0235-1","article-title":"Pharmacotherapy of acute mania: monotherapy or combination therapy with mood stabilizers and antipsychotics?","volume":"29","author":"Grande","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1124\/pharmrev.120.000007_bib179","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00023210-200923040-00005","article-title":"Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring","volume":"23","author":"Grandjean","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1124\/pharmrev.120.000007_bib180","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4088\/JCP.v63n1013","article-title":"Is response to prophylactic lithium a familial trait?","volume":"63","author":"Grof","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib181","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrneph.2009.43","article-title":"Lithium nephrotoxicity revisited","volume":"5","author":"Gr\u00fcnfeld","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/pharmrev.120.000007_bib182","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/15622975.2017.1384850","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder","volume":"19","author":"Grunze","year":"2018","journal-title":"World J Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib183","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/STROKEAHA.108.524504","article-title":"Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes","volume":"40","author":"Guo","year":"2009","journal-title":"Stroke"},{"key":"10.1124\/pharmrev.120.000007_bib184","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/tpj.2011.9","article-title":"Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling","volume":"12","author":"Gupta","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/pharmrev.120.000007_bib185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2019.05.016","article-title":"Targeting kinases in Parkinson\u2019s disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium","volume":"402","author":"Guttuso","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib186","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41380-020-0831-4","article-title":"Advances toward precision medicine for bipolar disorder: mechanisms & molecules","volume":"26","author":"Haggarty","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib187","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1503\/jpn.110143","article-title":"Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis","volume":"37","author":"Hajek","year":"2012","journal-title":"J Psychiatry Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib188","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1016\/S0021-9258(19)70391-3","article-title":"The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain","volume":"255","author":"Hallcher","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000007_bib189","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-190197","article-title":"Lithium as a Treatment for Alzheimer\u2019s Disease: The Systems Pharmacology Perspective","volume":"69","author":"Hampel","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/pharmrev.120.000007_bib190","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0092-8674(01)00412-3","article-title":"Regulation of GSK-3: a cellular multiprocessor","volume":"105","author":"Harwood","year":"2001","journal-title":"Cell"},{"key":"10.1124\/pharmrev.120.000007_bib191","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.mp.4001618","article-title":"Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited","volume":"10","author":"Harwood","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib192","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0028-3908(02)00217-4","article-title":"Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity","volume":"43","author":"Hashimoto","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib193","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainresrev.2004.02.003","article-title":"Critical role of brain-derived neurotrophic factor in mood disorders","volume":"45","author":"Hashimoto","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1124\/pharmrev.120.000007_bib194","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib195","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.4103\/1673-5374.313015","article-title":"Lithium beyond psychiatric indications: the reincarnation of a new old drug","volume":"16","author":"Haupt","year":"2021","journal-title":"Neural Regen Res"},{"key":"10.1124\/pharmrev.120.000007_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108357","article-title":"Lithium enhances post-stroke blood-brain barrier integrity, activates the MAPK\/ERK1\/2 pathway and alters immune cell migration in mice","volume":"181","author":"Haupt","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib197","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S1461145708009358","article-title":"Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder","volume":"12","author":"Hayashi","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib198","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/wps.20298","article-title":"Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records","volume":"15","author":"Hayes","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib199","first-page":"1012","article-title":"Inhibiting endoplasmic reticulum stress by lithium chloride contributes to the integrity of blood-spinal cord barrier and functional recovery after spinal cord injury","volume":"9","author":"He","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1124\/pharmrev.120.000007_bib200","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1101\/gad.1830709","article-title":"XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy","volume":"23","author":"Hetz","year":"2009","journal-title":"Genes Dev"},{"key":"10.1124\/pharmrev.120.000007_bib201","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/mp.2015.227","article-title":"Subcortical volumetric abnormalities in bipolar disorder","volume":"21","author":"Hibar","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1124\/pharmrev.120.000007_bib203","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.tpj.6500296","article-title":"Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2","volume":"5","author":"Hiroi","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/pharmrev.120.000007_bib204","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/foc.1.1.64","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"1","author":"Hirschfeld","year":"2003","journal-title":"Focus"},{"key":"10.1124\/pharmrev.120.000007_bib205","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib206","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12868-015-0222-y","article-title":"Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement","volume":"16","author":"Hou","year":"2015","journal-title":"BMC Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib207","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(16)00143-4","article-title":"Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study","volume":"387","author":"Hou","year":"2016","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.120.000007_bib208","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1017\/S0033291719004112","article-title":"Lithium prevents grey matter atrophy in patients with bipolar disorder: an international multicenter study","volume":"51","author":"Hozer","year":"2021","journal-title":"Psychol Med"},{"key":"10.1124\/pharmrev.120.000007_bib209","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.euroneuro.2022.01.112","article-title":"Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis","volume":"58","author":"Hsu","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/acps.13062","article-title":"A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder","volume":"140","author":"Hui","year":"2019","journal-title":"Acta Psychiatr Scand"},{"key":"10.1124\/pharmrev.120.000007_bib211","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.139","article-title":"Novel integrative genomic tool for interrogating lithium response in bipolar disorder","volume":"5","author":"Hunsberger","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib212","first-page":"450","article-title":"Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions","volume":"5","author":"Hunsberger","year":"2013","journal-title":"Am J Transl Res"},{"key":"10.1124\/pharmrev.120.000007_bib213","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1093\/brain\/awm190","article-title":"Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis","volume":"130","author":"Ilieva","year":"2007","journal-title":"Brain"},{"key":"10.1124\/pharmrev.120.000007_bib214","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1176\/ajp.156.10.1506","article-title":"Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge","volume":"156","author":"Ikonomov","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib215","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.nbd.2009.08.013","article-title":"Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice","volume":"36","author":"Ito","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pharmrev.120.000007_bib216","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/WNF.0000000000000039","article-title":"Haplotype analysis of GSK-3\u03b2 gene polymorphisms in bipolar disorder lithium responders and nonresponders","volume":"37","author":"Iwahashi","year":"2014","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib217","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"key":"10.1124\/pharmrev.120.000007_bib218","doi-asserted-by":"crossref","first-page":"22253","DOI":"10.1074\/jbc.M116.752634","article-title":"Valproate Induces the Unfolded Protein Response by Increasing Ceramide Levels","volume":"291","author":"Jadhav","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000007_bib219","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1365-4632.2008.03873.x","article-title":"Lithium and skin: dermatologic manifestations of lithium therapy","volume":"47","author":"Jafferany","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1124\/pharmrev.120.000007_bib220","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pnpbp.2015.11.014","article-title":"Mitochondrial impairment, apoptosis and autophagy in a rat brain as immediate and long-term effects of perinatal phencyclidine treatment - influence of restraint stress","volume":"66","author":"Jevti\u0107","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib221","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuropharm.2016.04.020","article-title":"Behavioral, neurochemical and molecular changes after acute deep brain stimulation of the infralimbic prefrontal cortex","volume":"108","author":"Jim\u00e9nez-S\u00e1nchez","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib222","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3390\/ijms17122129","article-title":"Downregulation of Homer1b\/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic Acid","volume":"17","author":"Jiang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib223","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnmol.2011.00016","article-title":"Glycogen synthase kinase-3 in the etiology and treatment of mood disorders","volume":"4","author":"Jope","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib224","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tibs.2016.10.009","article-title":"Stressed and Inflamed, Can GSK3 Be Blamed?","volume":"42","author":"Jope","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/pharmrev.120.000007_bib225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/pharmrev.120.000007_bib226","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1124\/pharmrev.120.000007_bib227","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpsychires.2009.11.002","article-title":"Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain","volume":"44","author":"Jornada","year":"2010","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pharmrev.120.000007_bib228","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5607\/en.2014.23.1.28","article-title":"Disturbance of the glutamatergic system in mood disorders","volume":"23","author":"Jun","year":"2014","journal-title":"Exp Neurobiol"},{"key":"10.1124\/pharmrev.120.000007_bib229","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00424-021-02543-0","article-title":"Lithium enhances exercise-induced glycogen breakdown and insulin-induced AKT activation to facilitate glucose uptake in rodent skeletal muscle","volume":"473","author":"Jung","year":"2021","journal-title":"Pflugers Arch"},{"key":"10.1124\/pharmrev.120.000007_bib230","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.biopsych.2004.01.008","article-title":"Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus","volume":"55","author":"Kaidanovich-Beilin","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib231","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004134","article-title":"Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94","volume":"4","author":"Kakiuchi","year":"2009","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000007_bib232","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng1235","article-title":"Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder","volume":"35","author":"Kakiuchi","year":"2003","journal-title":"Nat Genet"},{"key":"10.1124\/pharmrev.120.000007_bib233","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2017.01.007","article-title":"Effects of acute and chronic quercetin administration on methylphenidate-induced hyperlocomotion and oxidative stress","volume":"171","author":"Kanazawa","year":"2017","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.120.000007_bib234","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/mol.64.2.228","article-title":"Calcium-dependent prevention of neuronal apoptosis by lithium ion: essential role of phosphoinositide 3-kinase and phospholipase Cgamma","volume":"64","author":"Kang","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib235","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/jcbfm.2014.104","article-title":"Highly energized inhibitory interneurons are a central element for information processing in cortical networks","volume":"34","author":"Kann","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/pharmrev.120.000007_bib236","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.biopsych.2006.04.036","article-title":"Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims","volume":"61","author":"Karege","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib237","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1358\/dnp.2006.19.10.1068006","article-title":"The role of mitochondrial dysfunction in bipolar disorder","volume":"19","author":"Kato","year":"2006","journal-title":"Drug News Perspect"},{"key":"10.1124\/pharmrev.120.000007_bib238","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamapsychiatry.2021.3170","article-title":"Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder: A Randomized Clinical Trial","volume":"79","author":"Katz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib239","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2020.05.015","article-title":"Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders","volume":"106","author":"Kavalali","year":"2020","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.120.000007_bib240","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib241","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fnmol.2018.00297","article-title":"Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models","volume":"11","author":"Kerr","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib242","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006593","article-title":"Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer\u2019s disease","volume":"13","author":"Kerr","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1124\/pharmrev.120.000007_bib243","first-page":"255","article-title":"Increased bcl-2 protein levels in rat primary astrocyte culture following chronic lithium treatment","volume":"38","author":"Keshavarz","year":"2013","journal-title":"Iran J Med Sci"},{"key":"10.1124\/pharmrev.120.000007_bib244","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.13070","article-title":"Lithium as the drug of choice for maintenance treatment in bipolar disorder","volume":"140","author":"Kessing","year":"2019","journal-title":"Acta Psychiatr Scand"},{"key":"10.1124\/pharmrev.120.000007_bib245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1399-5618.2009.00788.x","article-title":"Does lithium protect against dementia?","volume":"12","author":"Kessing","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib246","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/YIC.0b013e32834a5cd0","article-title":"Predictors of excellent response to lithium: results from a nationwide register-based study","volume":"26","author":"Kessing","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib247","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jamapsychiatry.2015.1834","article-title":"Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease: A Nationwide Population-Based Study","volume":"72","author":"Kessing","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib248","first-page":"680","article-title":"Effects of lithium on oxidative stress parameters in healthy subjects","volume":"5","author":"Khairova","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1124\/pharmrev.120.000007_bib249","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuroscience.2014.12.018","article-title":"Neuroprotective effect of hemeoxygenase-1\/glycogen synthase kinase-3\u03b2 modulators in 3-nitropropionic acid-induced neurotoxicity in rats","volume":"287","author":"Khan","year":"2015","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.120.000007_bib250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1741-7015-10-131","article-title":"Using lithium as a neuroprotective agent in patients with cancer","volume":"10","author":"Khasraw","year":"2012","journal-title":"BMC Med"},{"key":"10.1124\/pharmrev.120.000007_bib251","doi-asserted-by":"crossref","first-page":"E402","DOI":"10.1503\/jpn.200185","article-title":"Chronic lithium treatment alters the excitatory\/ inhibitory balance of synaptic networks and reduces mGluR5-PKC signalling in mouse cortical neurons","volume":"46","author":"Khayachi","year":"2021","journal-title":"J Psychiatry Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib252","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6614-6-3","article-title":"Spectrum of lithium induced thyroid abnormalities: a current perspective","volume":"6","author":"Kibirige","year":"2013","journal-title":"Thyroid Res"},{"key":"10.1124\/pharmrev.120.000007_bib253","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.redox.2017.04.006","article-title":"Particular phosphorylation of PI3K\/Akt on Thr308 via PDK-1 and PTEN mediates melatonin\u2019s neuroprotective activity after focal cerebral ischemia in mice","volume":"12","author":"Kilic","year":"2017","journal-title":"Redox Biol"},{"key":"10.1124\/pharmrev.120.000007_bib254","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.psychres.2008.05.010","article-title":"Preliminary evidence on the association between XBP1-116C\/G polymorphism and response to prophylactic treatment with valproate in bipolar disorders","volume":"168","author":"Kim","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1124\/pharmrev.120.000007_bib255","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1124\/mol.108.052357","article-title":"Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides","volume":"75","author":"Kim","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib256","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.bbadis.2013.06.010","article-title":"Egr1 regulates lithium-induced transcription of the Period 2 (PER2) gene","volume":"1832","author":"Kim","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.120.000007_bib257","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jnr.22700","article-title":"Lithium protects against oxidative stress-mediated cell death in \u03b1-synuclein-overexpressing in vitro and in vivo models of Parkinson\u2019s disease","volume":"89","author":"Kim","year":"2011","journal-title":"J Neurosci Res"},{"key":"10.1124\/pharmrev.120.000007_bib258","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(01)03005-0","article-title":"Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium","volume":"919","author":"King","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000007_bib259","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1385\/JMN:24:2:237","article-title":"Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha","volume":"24","author":"Kirshenboim","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib260","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1038\/s41380-020-00946-6","article-title":"Mood stabilizers and\/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials","volume":"26","author":"Kishi","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib261","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41380-021-01334-4","article-title":"Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials","volume":"27","author":"Kishi","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib262","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2174\/1568026620666200607190951","article-title":"PTML Modeling for Alzheimer\u2019s Disease: Design and Prediction of Virtual Multi-Target Inhibitors of GSK3B, HDAC1, and HDAC6","volume":"20","author":"Kleandrova","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/pharmrev.120.000007_bib263","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000007_bib264","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.mp.4001471","article-title":"Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium","volume":"9","author":"Knable","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib265","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1073\/pnas.232693499","article-title":"Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients","volume":"100","author":"Koh","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000007_bib266","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/00048674221077619","article-title":"Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes","volume":"57","author":"K\u00f6hler-Forsberg","year":"2023","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib267","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-210607","article-title":"Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer\u2019s Disease Neuropathology","volume":"87","author":"Kok","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/pharmrev.120.000007_bib268","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136003","article-title":"Mini-review: Brain energy metabolism and its role in animal models of depression, bipolar disorder, schizophrenia and autism","volume":"760","author":"Kolar","year":"2021","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000007_bib269","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.biopsych.2019.05.020","article-title":"Role of Mesolimbic Brain-Derived Neurotrophic Factor in Depression","volume":"86","author":"Koo","year":"2019","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib270","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nrn2037","article-title":"The neuronal microRNA system","volume":"7","author":"Kosik","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib271","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12604","article-title":"Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1G93A) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes","volume":"19","author":"Kreilaus","year":"2020","journal-title":"Genes Brain Behav"},{"key":"10.1124\/pharmrev.120.000007_bib272","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.psyneuen.2014.02.004","article-title":"A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania","volume":"43","author":"Kulkarni","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1124\/pharmrev.120.000007_bib273","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1399-5618.2007.00467.x","article-title":"Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder","volume":"9","author":"Kupka","year":"2007","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib274","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/acps.13277","article-title":"Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta-analysis","volume":"143","author":"Lambrichts","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"10.1124\/pharmrev.120.000007_bib275","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bdi.12336","article-title":"A reduced risk of stroke with lithium exposure in bipolar disorder: a population-based retrospective cohort study","volume":"17","author":"Lan","year":"2015","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib276","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.mp.4002130","article-title":"Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder","volume":"14","author":"Lan","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib277","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1399-3011.1999.00083.x","article-title":"Expression analysis of glycogen synthase kinase-3 in human tissues","volume":"54","author":"Lau","year":"1999","journal-title":"J Pept Res"},{"key":"10.1124\/pharmrev.120.000007_bib278","doi-asserted-by":"crossref","first-page":"22558","DOI":"10.3390\/ijms141122558","article-title":"Neuroprotective effects of psychotropic drugs in Huntington\u2019s disease","volume":"14","author":"Lauterbach","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib279","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1089\/thy.1998.8.909","article-title":"The effects of lithium therapy on thyroid and thyrotropin-releasing hormone","volume":"8","author":"Lazarus","year":"1998","journal-title":"Thyroid"},{"key":"10.1124\/pharmrev.120.000007_bib280","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fnins.2015.00403","article-title":"Potential application of lithium in Parkinson\u2019s and other neurodegenerative diseases","volume":"9","author":"Lazzara","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib281","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/cn500040g","article-title":"A new avenue for lithium: intervention in traumatic brain injury","volume":"5","author":"Leeds","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib282","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"key":"10.1124\/pharmrev.120.000007_bib800","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1124\/pharmrev.120.000007_bib287","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00207454.2012.729234","article-title":"Therapeutic effects of valproate combined with lithium carbonate on MPTP-induced parkinsonism in mice: possible mediation through enhanced autophagy","volume":"123","author":"Li","year":"2013","journal-title":"Int J Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib288","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113607","article-title":"The mood-stabilizer lithium prevents hippocampal apoptosis and improves spatial memory in experimental meningitis","volume":"9","author":"Liechti","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000007_bib289","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI8541","article-title":"Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide","volume":"105","author":"Lien","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.120.000007_bib290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2014.10.032","article-title":"Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model","volume":"1591","author":"Lieu","year":"2014","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000007_bib291","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/mp.2014.123","article-title":"APOE and BDNF polymorphisms moderate amyloid \u03b2-related cognitive decline in preclinical Alzheimer\u2019s disease","volume":"20","author":"Lim","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib292","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fncel.2019.00450","article-title":"Molecular Mechanisms Linking ALS\/FTD and Psychiatric Disorders, the Potential Effects of Lithium","volume":"13","author":"Limanaqi","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib293","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer","volume":"15","author":"Lin","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/pharmrev.120.000007_bib294","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bdi.13078","article-title":"Clinical predictors of non-response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) study","volume":"23","author":"Lin","year":"2021","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib295","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1172\/JCI90259","article-title":"Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder","volume":"127","author":"Lipstein","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.120.000007_bib296","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/npp.2013.128","article-title":"GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine","volume":"38","author":"Liu","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib297","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.biopsych.2017.09.006","article-title":"Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study: Subcortical Volumetry Results From Posttraumatic Stress Disorder Consortia","volume":"83","author":"Logue","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib298","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2045-5380-2-15","article-title":"Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation","volume":"2","author":"Lowthert","year":"2012","journal-title":"Biol Mood Anxiety Disord"},{"key":"10.1124\/pharmrev.120.000007_bib299","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainresbull.2015.02.008","article-title":"Prophylactic lithium alleviates splenectomy-induced cognitive dysfunction possibly by inhibiting hippocampal TLR4 activation in aged rats","volume":"114","author":"Lu","year":"2015","journal-title":"Brain Res Bull"},{"key":"10.1124\/pharmrev.120.000007_bib300","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.conb.2018.07.009","article-title":"Gamma oscillations in cognitive disorders","volume":"52","author":"Mably","year":"2018","journal-title":"Curr Opin Neurobiol"},{"issue":"Suppl 2","key":"10.1124\/pharmrev.120.000007_bib301","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1399-5618.2009.00714.x","article-title":"The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis","volume":"11","author":"Machado-Vieira","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib302","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jad.2016.04.021","article-title":"Peripheral whole blood microRNA alterations in major depression and bipolar disorder","volume":"200","author":"Maffioletti","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib303","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/jnnp-2012-303645","article-title":"Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes","volume":"84","author":"Makin","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib304","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-013-0039-0","article-title":"Potential mechanisms of action of lithium in bipolar disorder. Current understanding","volume":"27","author":"Malhi","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1124\/pharmrev.120.000007_bib305","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0004867415617657","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"49","author":"Malhi","year":"2015","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib306","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40263-016-0380-1","article-title":"Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding","volume":"30","author":"Malhi","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1124\/pharmrev.120.000007_bib307","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jad.2017.03.052","article-title":"The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines","volume":"217","author":"Malhi","year":"2017","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib308","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/bdi.13036","article-title":"The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary","volume":"22","author":"Malhi","year":"2020","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib309","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065636","article-title":"Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report","volume":"8","author":"Manchia","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000007_bib310","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/bdi.12781","article-title":"Lithium and bipolar depression","volume":"21","author":"Manchia","year":"2019","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib311","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jamapsychiatry.2022.0081","article-title":"Suicide Risk and Lithium","volume":"79","author":"Manchia","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib312","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0006-3223(00)00929-X","article-title":"Signaling: cellular insights into the pathophysiology of bipolar disorder","volume":"48","author":"Manji","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib313","first-page":"259","article-title":"Burden of illness in bipolar depression","volume":"7","author":"Manning","year":"2005","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib314","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4088\/JCP.v69n0605","article-title":"Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD","volume":"69","author":"Marangell","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib315","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136116","article-title":"Mini review: Recent advances on epigenetic effects of lithium","volume":"761","author":"Marie-Claire","year":"2021","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000007_bib316","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1124\/pharmrev.120.000007_bib317","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/NMD.0000000000000583","article-title":"Functional Outcome in the Middle Course of Bipolar Disorder: A Longitudinal Study","volume":"205","author":"Martino","year":"2017","journal-title":"J Nerv Ment Dis"},{"key":"10.1124\/pharmrev.120.000007_bib318","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-150437","article-title":"Lithium as a Treatment for Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"48","author":"Matsunaga","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/pharmrev.120.000007_bib319","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2217\/pgs.10.127","article-title":"Pharmacogenetics of lithium response in bipolar disorder","volume":"11","author":"McCarthy","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1124\/pharmrev.120.000007_bib320","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.euroneuro.2016.05.003","article-title":"Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients","volume":"26","author":"McCarthy","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib321","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.90","article-title":"Genetic and clinical factors predict lithium\u2019s effects on PER2 gene expression rhythms in cells from bipolar disorder patients","volume":"3","author":"McCarthy","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib322","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3233\/JPD-229002","article-title":"Parkinson\u2019s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update","volume":"12","author":"McFarthing","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"10.1124\/pharmrev.120.000007_bib323","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jamapsychiatry.2017.2336","article-title":"Could Lithium in Drinking Water Reduce the Incidence of Dementia?","volume":"74","author":"McGrath","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib324","article-title":"A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder","volume":"13","author":"McIntyre","year":"2011","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1124\/pharmrev.120.000007_bib325","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.120.000007_bib326","first-page":"CD004048","article-title":"Lithium for acute mania","volume":"6","author":"McKnight","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pharmrev.120.000007_bib327","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00268-017-4328-5","article-title":"Lithium-Associated Hypercalcemia: Pathophysiology, Prevalence, Management","volume":"42","author":"Meehan","year":"2018","journal-title":"World J Surg"},{"key":"10.1124\/pharmrev.120.000007_bib328","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature15526","article-title":"Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder [published correction appears in Nature (2016) 530:242]","volume":"527","author":"Mertens","year":"2015","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000007_bib329","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1038\/s41380-021-01048-7","article-title":"Circadian rhythms in bipolar disorder patient-derived neurons predict lithium response: preliminary studies","volume":"26","author":"Mishra","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib330","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/WNF.0000000000000028","article-title":"The effect of lithium in post-stroke motor recovery: a double-blind, placebo-controlled, randomized clinical trial","volume":"37","author":"Mohammadianinejad","year":"2014","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib331","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mp.2013.105","article-title":"Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)","volume":"19","author":"Molendijk","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib332","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s12192-018-0897-y","article-title":"Amyotrophic lateral sclerosis (ALS) and Alzheimer\u2019s disease (AD) are characterised by differential activation of ER stress pathways: focus on UPR target genes","volume":"23","author":"Montibeller","year":"2018","journal-title":"Cell Stress Chaperones"},{"key":"10.1124\/pharmrev.120.000007_bib333","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(00)02793-8","article-title":"Lithium-induced increase in human brain grey matter [published correction appears in Lancet (2000) 356:2104]","volume":"356","author":"Moore","year":"2000","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.120.000007_bib334","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/1567205013666160219113112","article-title":"The Putative Use of Lithium in Alzheimer\u2019s Disease","volume":"13","author":"Morris","year":"2016","journal-title":"Curr Alzheimer Res"},{"issue":"Pt A","key":"10.1124\/pharmrev.120.000007_bib335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2017.01.014","article-title":"A model of the mitochondrial basis of bipolar disorder","volume":"74","author":"Morris","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pharmrev.120.000007_bib336","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/cn500056q","article-title":"Lithium and autophagy","volume":"5","author":"Motoi","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib337","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000314309","article-title":"Lithium reduces pathological aggression and suicidality: a mini-review","volume":"62","author":"M\u00fcller-Oerlinghausen","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1124\/pharmrev.120.000007_bib338","doi-asserted-by":"crossref","DOI":"10.1017\/S204579602200049X","article-title":"Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials","volume":"31","author":"Nabi","year":"2022","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1124\/pharmrev.120.000007_bib339","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8","article-title":"Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain","volume":"426","author":"Naik","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1124\/pharmrev.120.000007_bib340","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/npr2.12027","article-title":"De novo UNC13B mutation identified in a bipolar disorder patient increases a rare exon-skipping variant","volume":"38","author":"Nakamura","year":"2018","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1124\/pharmrev.120.000007_bib341","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00401-005-1087-4","article-title":"Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies","volume":"110","author":"Nakashima","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1124\/pharmrev.120.000007_bib342","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/jat.3093","article-title":"Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C \u03b4 in human neuroblastoma dopaminergic SH-SY5Y cell lines","volume":"35","author":"Nam","year":"2015","journal-title":"J Appl Toxicol"},{"key":"10.1124\/pharmrev.120.000007_bib343","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jad.2014.05.053","article-title":"A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression","volume":"168","author":"Nelson","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib344","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2021.08.264","article-title":"Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials","volume":"54","author":"Nestsiarovich","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib345","series-title":"Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care","year":"2014"},{"key":"10.1124\/pharmrev.120.000007_bib346","article-title":"Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis","author":"Niemsiri","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib347","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jnc.14034","article-title":"Exercise and BDNF reduce A\u03b2 production by enhancing \u03b1-secretase processing of APP","volume":"142","author":"Nigam","year":"2017","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000007_bib348","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jad.2010.05.018","article-title":"New treatment guidelines for acute bipolar depression: a systematic review","volume":"129","author":"Nivoli","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib349","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2020.100869","article-title":"Neuropsychiatric effects of tamoxifen: Challenges and opportunities","volume":"59","author":"Novick","year":"2020","journal-title":"Front Neuroendocrinol"},{"key":"10.1124\/pharmrev.120.000007_bib350","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1215\/15228517-2008-041","article-title":"Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3","volume":"10","author":"Nowicki","year":"2008","journal-title":"Neuro-oncol"},{"key":"10.1124\/pharmrev.120.000007_bib351","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1523\/JNEUROSCI.4753-03.2004","article-title":"Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium","volume":"24","author":"O\u2019Brien","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib352","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1172\/JCI45194","article-title":"Glycogen synthase kinase-3 is essential for \u03b2-arrestin-2 complex formation and lithium-sensitive behaviors in mice","volume":"121","author":"O\u2019Brien","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.120.000007_bib353","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10571-021-01129-9","article-title":"Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview","volume":"42","author":"Ochoa","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"10.1124\/pharmrev.120.000007_bib354","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/01.wnr.0000127348.64681.b2","article-title":"Neural synchronization deficits to auditory stimulation in bipolar disorder","volume":"15","author":"O\u2019Donnell","year":"2004","journal-title":"Neuroreport"},{"key":"10.1124\/pharmrev.120.000007_bib355","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.biopsych.2008.05.014","article-title":"Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania","volume":"64","author":"\u00d6ng\u00fcr","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib356","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1038\/s41380-021-01164-4","article-title":"Lithium increases mitochondrial respiration in iPSC-derived neural precursor cells from lithium responders","volume":"26","author":"Osete","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib357","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/s41380-023-01944-0","article-title":"Transcriptional and functional effects of lithium in bipolar disorder iPSC-derived cortical spheroids","volume":"28","author":"Osete","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib358","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejphar.2014.06.042","article-title":"Lithium: a review of pharmacology, clinical uses, and toxicity","volume":"740","author":"Oruch","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib359","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/membranes4030565","article-title":"Trafficking of kainate receptors","volume":"4","author":"Pahl","year":"2014","journal-title":"Membranes (Basel)"},{"key":"10.1124\/pharmrev.120.000007_bib360","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0269881118822167","article-title":"Tamoxifen for bipolar disorder: Systematic review and meta-analysis","volume":"33","author":"Palacios","year":"2019","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib361","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41398-021-01695-y","article-title":"Lithium treatment and human hippocampal neurogenesis","volume":"11","author":"Palmos","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib362","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnpbp.2013.01.008","article-title":"Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients","volume":"44","author":"Palomino","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib363","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/FBP.0b013e32833da5da","article-title":"Intracellular pathways underlying the effects of lithium","volume":"21","author":"Pasquali","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib364","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biopsych.2017.11.018","article-title":"Mitochondrial Etiology of Neuropsychiatric Disorders","volume":"83","author":"Pei","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib365","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1124\/pharmrev.120.000007_bib366","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ajmg.b.31153","article-title":"Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder","volume":"156","author":"Pereira","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1124\/pharmrev.120.000007_bib367","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.rpsm.2019.08.001","article-title":"Thyroid alterations in bipolar patients on treatment with lithium. Alteraciones tiroideas en pacientes bipolares a tratamiento con litio","volume":"14","author":"P\u00e9rez-Castro","year":"2021","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"10.1124\/pharmrev.120.000007_bib368","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"163","author":"Perlis","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib369","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1176\/appi.ajp.2009.08111633","article-title":"A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder","volume":"166","author":"Perlis","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib370","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1017\/S1461145714000443","article-title":"Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression","volume":"17","author":"Pfaffenseller","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib371","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1146\/annurev.pharmtox.41.1.789","article-title":"Molecular targets of lithium action","volume":"41","author":"Phiel","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/pharmrev.120.000007_bib372","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3alpha regulates production of Alzheimer\u2019s disease amyloid-\u03b2 peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000007_bib373","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib374","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40345-017-0091-7","article-title":"Cutaneous adverse reaction during lithium treatment: a case report and updated systematic review with meta-analysis","volume":"5","author":"Pinna","year":"2017","journal-title":"Int J Bipolar Disord"},{"issue":"Suppl 14","key":"10.1124\/pharmrev.120.000007_bib375","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1471-2105-13-S14-S10","article-title":"The human \u201cmagnesome\u201d: detecting magnesium binding sites on human proteins","volume":"13","author":"Piovesan","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"10.1124\/pharmrev.120.000007_bib376","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ddr.21341","article-title":"Lithium Pharmacogenetics: Where Do We Stand?","volume":"77","author":"Pisanu","year":"2016","journal-title":"Drug Dev Res"},{"key":"10.1124\/pharmrev.120.000007_bib377","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40291-018-0335-y","article-title":"The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine","volume":"22","author":"Pisanu","year":"2018","journal-title":"Mol Diagn Ther"},{"key":"10.1124\/pharmrev.120.000007_bib378","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.3390\/ijms20236040","article-title":"Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder","volume":"20","author":"Pisanu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib379","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nbd.2012.06.026","article-title":"NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease","volume":"48","author":"Pouladi","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pharmrev.120.000007_bib380","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.euroneuro.2011.09.008","article-title":"Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder","volume":"22","author":"Popovic","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib381","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10545-018-0168-1","article-title":"The role of suboptimal mitochondrial function in vulnerability to post-traumatic stress disorder","volume":"41","author":"Preston","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1124\/pharmrev.120.000007_bib382","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41398-021-01716-w","article-title":"Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression","volume":"11","author":"Price","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib383","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib384","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s12888-021-03572-w","article-title":"Obesity and metabolic comorbidity in bipolar disorder: do patients on lithium comprise a subgroup? A naturalistic study","volume":"21","author":"Prillo","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib385","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41398-021-01492-7","article-title":"Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders","volume":"11","author":"Puglisi-Allegra","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib386","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10616-016-0056-1","article-title":"Lithium chloride promotes neuronal differentiation of rat neural stem cells and enhances neural regeneration in Parkinson\u2019s disease model","volume":"69","author":"Qi","year":"2017","journal-title":"Cytotechnology"},{"key":"10.1124\/pharmrev.120.000007_bib387","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/neuro.06.013.2009","article-title":"A defined network of fast-spiking interneurons in orbitofrontal cortex: responses to behavioral contingencies and ketamine administration","volume":"3","author":"Quirk","year":"2009","journal-title":"Front Syst Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib388","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/mi.4.5.6","article-title":"Molecular effects of lithium","volume":"4","author":"Quiroz","year":"2004","journal-title":"Mol Interv"},{"key":"10.1124\/pharmrev.120.000007_bib389","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000314310","article-title":"Novel insights into lithium\u2019s mechanism of action: neurotrophic and neuroprotective effects","volume":"62","author":"Quiroz","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1124\/pharmrev.120.000007_bib390","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1874467210902020207","article-title":"Mood-stabilizers target the brain arachidonic acid cascade","volume":"2","author":"Rao","year":"2009","journal-title":"Curr Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib391","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jad.2022.04.058","article-title":"Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis","volume":"308","author":"Rakofsky","year":"2022","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib392","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1021\/acs.jpcb.1c05099","article-title":"Contrasting Effects of Inhibitors Li+ and Be2+ on Catalytic Cycle of Glycogen Synthase Kinase-3\u03b2","volume":"125","author":"Reilley","year":"2021","journal-title":"J Phys Chem B"},{"key":"10.1124\/pharmrev.120.000007_bib393","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fpsyt.2018.00207","article-title":"Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder","volume":"9","author":"Reinbold","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib394","doi-asserted-by":"crossref","first-page":"11903","DOI":"10.3390\/ijms160611903","article-title":"What\u2019s New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment","volume":"16","author":"Reis","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib395","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1073\/pnas.0937423100","article-title":"Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia\/reperfusion model","volume":"100","author":"Ren","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000007_bib396","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharep.2015.08.010","article-title":"Effects of ketamine administration on the phosphorylation levels of CREB and TrKB and on oxidative damage after infusion of MEK inhibitor","volume":"68","author":"R\u00e9us","year":"2016","journal-title":"Pharmacol Rep"},{"key":"10.1124\/pharmrev.120.000007_bib397","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1176\/appi.ajp.2020.19091000","article-title":"20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings","volume":"177","author":"Rhee","year":"2020","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib398","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mcn.2008.06.007","article-title":"Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death","volume":"39","author":"Rojo","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib399","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpsychires.2010.04.028","article-title":"MicroRNA-134 plasma levels before and after treatment for bipolar mania","volume":"45","author":"Rong","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pharmrev.120.000007_bib400","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1176\/appi.ajp.162.2.394","article-title":"Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study","volume":"162","author":"Rowland","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib401","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.2018.144","article-title":"Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses","volume":"213","author":"Rowland","year":"2018","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib402","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052658","article-title":"Lithium controls central nervous system autoimmunity through modulation of IFN-\u03b3 signaling","volume":"7","author":"Rowse","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000007_bib403","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrd3802","article-title":"Autophagy modulation as a potential therapeutic target for diverse diseases","volume":"11","author":"Rubinsztein","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.120.000007_bib404","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.euroneuro.2009.06.002","article-title":"Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions","volume":"19","author":"Rybakowski","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib405","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1017\/S1461145710000404","article-title":"Excellent lithium responders have normal cognitive functions and plasma BDNF levels","volume":"13","author":"Rybakowski","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib406","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0043-124436","article-title":"Clinical Perspectives of Lithium\u2019s Neuroprotective Effect","volume":"51","author":"Rybakowski","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib407","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.euroneuro.2022.01.111","article-title":"Lithium","volume":"57","author":"Rybakowski","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib408","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.euroneuro.2021.07.003","article-title":"Precision psychiatry: Complex problems require complex solutions","volume":"52","author":"Salagre","year":"2021","journal-title":"European Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib409","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00737-022-01234-8","article-title":"Obstetric outcomes regarding the use of lithium in pregnant women with bipolar disorders: a prospective cohort study","volume":"25","author":"Sagu\u00e9-Vilavella","year":"2022","journal-title":"Arch Women Ment Health"},{"key":"10.1124\/pharmrev.120.000007_bib410","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/ijms22041532","article-title":"Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium","volume":"22","author":"Sakrajda","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib411","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/hmg\/ddm294","article-title":"A rational mechanism for combination treatment of Huntington\u2019s disease using lithium and rapamycin","volume":"17","author":"Sarkar","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pharmrev.120.000007_bib412","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4161\/auto.2387","article-title":"Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations","volume":"2","author":"Sarkar","year":"2006","journal-title":"Autophagy"},{"key":"10.1124\/pharmrev.120.000007_bib413","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2006.06.009","article-title":"Lithium-induced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model","volume":"1108","author":"Sasaki","year":"2006","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000007_bib414","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/jnr.21604","article-title":"Dual roles of the MAPK\/ERK1\/2 cell signaling pathway after stroke","volume":"86","author":"Sawe","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1124\/pharmrev.120.000007_bib415","first-page":"108","article-title":"Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature [published correction appears in Mol Neuropsychiatry (2018) 3:180]","volume":"3","author":"Saxena","year":"2017","journal-title":"Mol Neuropsychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib416","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neubiorev.2016.06.040","article-title":"Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications","volume":"68","author":"Scaini","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pharmrev.120.000007_bib417","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1172\/JCI22466","article-title":"Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium","volume":"116","author":"Schlecker","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.120.000007_bib418","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.npp.1301575","article-title":"Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder","volume":"33","author":"Schloesser","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib419","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41398-021-01702-2","article-title":"Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients [published correction appears in Transl Psychiatry (2022) 12:278]","volume":"11","author":"Schubert","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib420","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000314708","article-title":"The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment","volume":"62","author":"Schulze","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1124\/pharmrev.120.000007_bib421","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0002-9343(73)90193-9","article-title":"Iodine and lithium-induced hypothyroidism. Documentation of synergism","volume":"55","author":"Shopsin","year":"1973","journal-title":"Am J Med"},{"key":"10.1124\/pharmrev.120.000007_bib422","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pnpbp.2014.08.013","article-title":"The role of neurotrophins in bipolar disorder","volume":"56","author":"Scola","year":"2015","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib423","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.neuroscience.2007.10.045","article-title":"Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells","volume":"151","author":"Seelan","year":"2008","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.120.000007_bib424","first-page":"176","article-title":"Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial","volume":"21","author":"Segal","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib425","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.mp.4001463","article-title":"Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington\u2019s disease","volume":"9","author":"Senatorov","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib426","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.lfs.2005.07.007","article-title":"Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells","volume":"78","author":"Shao","year":"2006","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.120.000007_bib427","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2005.04.052","article-title":"Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells","volume":"58","author":"Shao","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib428","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.bmcl.2007.06.006","article-title":"Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition","volume":"17","author":"Shi","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000007_bib429","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1089\/neu.2015.4177","article-title":"Inhibition of Glycogen Synthase Kinase-3: An Emerging Target in the Treatment of Traumatic Brain Injury","volume":"33","author":"Shim","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1124\/pharmrev.120.000007_bib430","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib431","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0026-0495(86)90170-8","article-title":"Symptomatic reactive hypoglycemia during glucose tolerance test in lithium-treated patients","volume":"35","author":"Shah","year":"1986","journal-title":"Metabolism"},{"issue":"Suppl 2, Suppl 2","key":"10.1124\/pharmrev.120.000007_bib432","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1399-5618.2009.00706.x","article-title":"The history of lithium therapy","volume":"11","author":"Shorter","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib433","doi-asserted-by":"crossref","first-page":"F703","DOI":"10.1152\/ajprenal.00189.2004","article-title":"Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors","volume":"288","author":"Sinha","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pharmrev.120.000007_bib434","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/cells10020255","article-title":"Lithium and Therapeutic Targeting of GSK-3","volume":"10","author":"Snitow","year":"2021","journal-title":"Cells"},{"key":"10.1124\/pharmrev.120.000007_bib435","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(00)00175-X","article-title":"Concurrent measures of protein kinase C and phosphoinositides in lithium-treated bipolar patients and healthy individuals: a preliminary study","volume":"95","author":"Soares","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1124\/pharmrev.120.000007_bib436","doi-asserted-by":"crossref","first-page":"44701","DOI":"10.1074\/jbc.M206047200","article-title":"Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation","volume":"277","author":"Song","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000007_bib437","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/0004867416664794","article-title":"Clinical factors associated with lithium response in bipolar disorders","volume":"51","author":"Sportiche","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib438","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2013.04.004","article-title":"Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients","volume":"73","author":"Squassina","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.120.000007_bib439","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2217\/pgs.11.102","article-title":"Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder","volume":"12","author":"Squassina","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1124\/pharmrev.120.000007_bib440","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.euroneuro.2020.03.005","article-title":"MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings","volume":"34","author":"Squassina","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib441","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.euroneuro.2015.10.008","article-title":"Telomere length in bipolar disorder and lithium response","volume":"27","author":"Squassina","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib442","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","article-title":"JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis","volume":"18","author":"Steelman","year":"2004","journal-title":"Leukemia"},{"key":"10.1124\/pharmrev.120.000007_bib443","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41598-020-80814-z","article-title":"Prediction of lithium response using genomic data","volume":"11","author":"Stone","year":"2021","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.120.000007_bib444","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.biopsych.2020.02.1181","article-title":"Accumulation of Lithium in the Hippocampus of Patients With Bipolar Disorder: A Lithium-7 Magnetic Resonance Imaging Study at 7 Tesla","volume":"88","author":"Stout","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031993","article-title":"Lithium treatment of APPSwDI\/NOS2-\/- mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype","volume":"7","author":"Sudduth","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000007_bib900","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.735622","article-title":"The Role of the UPR Pathway in the Pathophysiology and Treatment of Bipolar Disorder","volume":"15","author":"Suliman","year":"2021","journal-title":"Frontiers in cellular neuroscience"},{"key":"10.1124\/pharmrev.120.000007_bib446","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","article-title":"Depression during mania. Treatment response to lithium or divalproex","volume":"54","author":"Swann","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib447","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1530\/EJE-08-0620","article-title":"Lithium-associated hyperparathyroidism: report of four cases and review of the literature","volume":"160","author":"Szalat","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1124\/pharmrev.120.000007_bib448","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s11064-007-9310-4","article-title":"Caspase-dependent apoptosis induced by thapsigargin was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical neurons","volume":"32","author":"Takadera","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1124\/pharmrev.120.000007_bib449","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/JCP.0000000000000492","article-title":"Tamoxifen: A Protein Kinase C Inhibitor to Treat Mania: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials","volume":"36","author":"Talaei","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib450","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","article-title":"Benefits and limitations of genome-wide association studies","volume":"20","author":"Tam","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1124\/pharmrev.120.000007_bib451","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105586","article-title":"The interaction between autophagy and neuroinflammation in major depressive disorder: From pathophysiology to therapeutic implications","volume":"168","author":"Tang","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.120.000007_bib452","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbrc.2014.06.041","article-title":"Lithium potentiates GSK-3\u03b2 activity by inhibiting phosphoinositide 3-kinase-mediated Akt phosphorylation","volume":"450","author":"Tian","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pharmrev.120.000007_bib453","first-page":"2441","article-title":"Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects","volume":"11","author":"Toker","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1124\/pharmrev.120.000007_bib454","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.bbrc.2017.12.119","article-title":"Lithium chloride contributes to blood-spinal cord barrier integrity and functional recovery from spinal cord injury by stimulating autophagic flux","volume":"495","author":"Tong","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pharmrev.120.000007_bib455","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2009.01.028","article-title":"Brain-derived neurotrophic factor serum levels before and after treatment for acute mania","volume":"452","author":"Tramontina","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000007_bib456","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD","volume":"133","author":"Tramutola","year":"2015","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000007_bib457","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00213-008-1311-8","article-title":"Lithium and cognitive enhancement: leave it or take it?","volume":"202","author":"Tsaltas","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.120.000007_bib458","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nn1659","article-title":"Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action","volume":"9","author":"Tsankova","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib459","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jad.2014.05.012","article-title":"Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium","volume":"166","author":"Tunca","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib460","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/sj.mp.4000888","article-title":"Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium","volume":"6","author":"Turecki","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib461","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881118822161","article-title":"Lithium treatment for unipolar major depressive disorder: Systematic review","volume":"33","author":"Undurraga","year":"2019","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib462","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jad.2012.01.027","article-title":"Bipolar depression: clinical correlates of receiving antidepressants","volume":"139","author":"Undurraga","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib463","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/cells10020230","article-title":"Parkinson\u2019s Disease: Potential Actions of Lithium by Targeting the WNT\/\u03b2-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway","volume":"10","author":"Vall\u00e9e","year":"2021","journal-title":"Cells"},{"key":"10.1124\/pharmrev.120.000007_bib464","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2012.00001","article-title":"GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder","volume":"5","author":"Valvezan","year":"2012","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib465","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/wps.20309","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib466","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1212\/WNL.0000000000004606","article-title":"Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials","volume":"89","author":"van Eijk","year":"2017","journal-title":"Neurology"},{"key":"10.1124\/pharmrev.120.000007_bib467","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mp.2015.118","article-title":"Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium","volume":"21","author":"van Erp","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib468","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mito.2022.03.002","article-title":"Reviewing the mitochondrial dysfunction paradigm in rodent models as platforms for neuropsychiatric disease research","volume":"64","author":"van Rensburg","year":"2022","journal-title":"Mitochondrion"},{"key":"10.1124\/pharmrev.120.000007_bib469","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2018.01.035","article-title":"Expression analysis of protein homeostasis pathways in the peripheral blood mononuclear cells of sporadic amyotrophic lateral sclerosis patients","volume":"387","author":"Vats","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib470","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.euroneuro.2015.07.013","article-title":"Recurrence rates in bipolar disorder: Systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials","volume":"25","author":"V\u00e1zquez","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib471","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/02698811211013579","article-title":"Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium","volume":"35","author":"V\u00e1zquez","year":"2021","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib472","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102167","article-title":"Lithium treatment impacts nucleus accumbens shape in bipolar disorder","volume":"25","author":"Vecchio","year":"2020","journal-title":"Neuroimage Clin"},{"key":"10.1124\/pharmrev.120.000007_bib473","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/acps.13153","article-title":"Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses","volume":"141","author":"Velosa","year":"2020","journal-title":"Acta Psychiatr Scand"},{"key":"10.1124\/pharmrev.120.000007_bib474","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bdi.13040","article-title":"Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms","volume":"23","author":"Verdolini","year":"2021","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib476","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40263-013-0073-y","article-title":"Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis","volume":"27","author":"Vieta","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1124\/pharmrev.120.000007_bib477","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1124\/pharmrev.120.000007_bib478","doi-asserted-by":"crossref","first-page":"26551","DOI":"10.1021\/acsomega.0c03302","article-title":"Machine Learning for Discovery of GSK3\u03b2 Inhibitors","volume":"5","author":"Vignaux","year":"2020","journal-title":"ACS Omega"},{"key":"10.1124\/pharmrev.120.000007_bib479","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41398-019-0434-5","article-title":"Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance","volume":"9","author":"Walker","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib480","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0006-3223(95)00611-7","article-title":"Enhanced protein kinase C activity and translocation in bipolar affective disorder brains","volume":"40","author":"Wang","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib481","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3956(98)90057-7","article-title":"Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients","volume":"33","author":"Wang","year":"1999","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pharmrev.120.000007_bib482","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neuroscience.2015.06.002","article-title":"Notch pathway is activated in cell culture and mouse models of mutant SOD1-related familial amyotrophic lateral sclerosis, with suppression of its activation as an additional mechanism of neuroprotection for lithium and valproate","volume":"301","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.120.000007_bib483","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12242","article-title":"Effects of chronic lithium administration on renal acid excretion in humans and rats","volume":"2","author":"Weiner","year":"2014","journal-title":"Physiol Rep"},{"key":"10.1124\/pharmrev.120.000007_bib484","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.wneu.2017.07.093","article-title":"Traumatic Brain Injury and Mood Stabilizers: Recent Cumulative Evidence","volume":"105","author":"Welling","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1124\/pharmrev.120.000007_bib485","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.2147\/NDT.S282208","article-title":"Ketamine in Bipolar Disorder: A Review","volume":"16","author":"Wilkowska","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1124\/pharmrev.120.000007_bib486","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib487","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-190862","article-title":"NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats","volume":"73","author":"Wilson","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/pharmrev.120.000007_bib488","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.4088\/JCP.08r04972","article-title":"Effects of lithium on cognitive performance: a meta-analysis","volume":"70","author":"Wingo","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib489","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3390\/ijms18122679","article-title":"An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms","volume":"18","author":"Won","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.120.000007_bib490","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/1673-5374.198964","article-title":"Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury","volume":"12","author":"Wurzelmann","year":"2017","journal-title":"Neural Regen Res"},{"key":"10.1124\/pharmrev.120.000007_bib491","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00001756-200203250-00029","article-title":"Decreased prefrontal CaMKII \u03b1 mRNA in bipolar illness","volume":"13","author":"Xing","year":"2002","journal-title":"Neuroreport"},{"key":"10.1124\/pharmrev.120.000007_bib492","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuroscience.2011.10.031","article-title":"Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y","volume":"199","author":"Xiong","year":"2011","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.120.000007_bib493","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.STR.0000066308.25088.64","article-title":"Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death","volume":"34","author":"Xu","year":"2003","journal-title":"Stroke"},{"key":"10.1124\/pharmrev.120.000007_bib494","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/glia.22491","article-title":"Nerve injury induces glial cell line-derived neurotrophic factor (GDNF) expression in Schwann cells through purinergic signaling and the PKC-PKD pathway","volume":"61","author":"Xu","year":"2013","journal-title":"Glia"},{"key":"10.1124\/pharmrev.120.000007_bib495","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/858251","article-title":"Lithium and Valproate Levels Do Not Correlate with Ketamine\u2019s Antidepressant Efficacy in Treatment-Resistant Bipolar Depression","volume":"2015","author":"Xu","year":"2015","journal-title":"Neural Plast"},{"key":"10.1124\/pharmrev.120.000007_bib496","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000430823","article-title":"Downregulation of BDNF Expression by PKC and by TNF-\u03b1 in Human Endothelial Cells","volume":"96","author":"Xu","year":"2015","journal-title":"Pharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib497","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuropharm.2007.06.020","article-title":"Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia","volume":"53","author":"Yan","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib498","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbr.2006.11.021","article-title":"Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia","volume":"177","author":"Yan","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.120.000007_bib499","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sc.2011.126","article-title":"Efficacy and safety of lithium carbonate treatment of chronic spinal cord injuries: a double-blind, randomized, placebo-controlled clinical trial","volume":"50","author":"Yang","year":"2012","journal-title":"Spinal Cord"},{"key":"10.1124\/pharmrev.120.000007_bib500","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0891-0618(02)00014-5","article-title":"Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain","volume":"23","author":"Yao","year":"2002","journal-title":"J Chem Neuroanat"},{"key":"10.1124\/pharmrev.120.000007_bib501","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.mp.4002099","article-title":"The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons","volume":"14","author":"Yasuda","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib502","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.psc.2005.01.001","article-title":"Atypical antipsychotics for bipolar disorder","volume":"28","author":"Yatham","year":"2005","journal-title":"Psychiatr Clin North Am"},{"key":"10.1124\/pharmrev.120.000007_bib503","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib504","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archgenpsychiatry.2007.43","article-title":"Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen","volume":"65","author":"Yildiz","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib505","first-page":"125","article-title":"Antimanic Treatment With Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study","volume":"1","author":"Yildiz","year":"2016","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1124\/pharmrev.120.000007_bib506","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-2571(00)00025-X","article-title":"An expanded view of inositol signaling","volume":"41","author":"York","year":"2001","journal-title":"Adv Enzyme Regul"},{"key":"10.1124\/pharmrev.120.000007_bib507","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1073\/pnas.92.11.5149","article-title":"Definition of a metal-dependent\/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure","volume":"92","author":"York","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000007_bib508","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3171\/2013.6.JNS13135","article-title":"Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury","volume":"119","author":"Yu","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1124\/pharmrev.120.000007_bib509","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2217\/fnl-2016-0003","article-title":"Inositol depletion, GSK3 inhibition and bipolar disorder","volume":"11","author":"Yu","year":"2016","journal-title":"Future Neurol"},{"key":"10.1124\/pharmrev.120.000007_bib510","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jad.2009.10.017","article-title":"Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia","volume":"124","author":"Yuan","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.120.000007_bib511","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jgg.2014.12.001","article-title":"Impaired autophagy in hilar mossy cells of the dentate gyrus and its implication in schizophrenia","volume":"42","author":"Yuan","year":"2015","journal-title":"J Genet Genomics"},{"key":"10.1124\/pharmrev.120.000007_bib513","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.872134","article-title":"The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases","volume":"14","author":"Zang","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib514","doi-asserted-by":"crossref","DOI":"10.1038\/srep40726","article-title":"Lithium Accumulates in Neurogenic Brain Regions as Revealed by High Resolution Ion Imaging","volume":"7","author":"Zanni","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.120.000007_bib515","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000007_bib516","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1196\/annals.1300.017","article-title":"Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system","volume":"1003","author":"Zarate","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/pharmrev.120.000007_bib517","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.biopsych.2005.10.021","article-title":"Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder","volume":"59","author":"Zarate","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib518","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bdi.12452","article-title":"GSK-3: A key regulatory target for ketamine\u2019s rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput","volume":"18","author":"Zarate","year":"2016","journal-title":"Bipolar Disord"},{"key":"10.1124\/pharmrev.120.000007_bib519","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2165\/00023210-200923070-00003","article-title":"Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder","volume":"23","author":"Zarate","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1124\/pharmrev.120.000007_bib520","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pharmrev.120.000007_bib521","doi-asserted-by":"crossref","first-page":"33067","DOI":"10.1074\/jbc.M212635200","article-title":"Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000007_bib522","first-page":"4989","article-title":"Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson\u2019s disease via regulation of \u03b1-synuclein methylation","volume":"19","author":"Zhao","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1124\/pharmrev.120.000007_bib523","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028441","article-title":"Regulation of brain-derived neurotrophic factor exon IV transcription through calcium responsive elements in cortical neurons","volume":"6","author":"Zheng","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000007_bib524","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1523\/JNEUROSCI.4530-04.2005","article-title":"The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers","volume":"25","author":"Zhou","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000007_bib525","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/npp.2008.131","article-title":"Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers","volume":"34","author":"Zhou","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000007_bib526","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.566058","article-title":"Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3\u03b2 Inhibitors","volume":"11","author":"Zhu","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.120.000007_bib527","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023341","article-title":"Lithium suppresses astrogliogenesis by neural stem and progenitor cells by inhibiting STAT3 pathway independently of glycogen synthase kinase 3 beta","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000007_bib528","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.brainresbull.2010.07.008","article-title":"Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice","volume":"83","author":"Zhu","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.1124\/pharmrev.120.000007_bib529","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111312","article-title":"The miRNome of Depression","volume":"22","author":"\u017burawek","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724006197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724006197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pharmrev.120.000007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:19:28Z","timestamp":1740053968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724006197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":526,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0031699724006197"],"URL":"https:\/\/doi.org\/10.1124\/pharmrev.120.000007","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pharmrev.120.000007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}